Instrument Inactif

Communiqués Constellation Pharmaceuticals, Inc.

Actions

CNST

US2103731061

Recherche biotechnologique et médicale

Communiqués

15/07/21	Constellation Pharmaceuticals : Completion of Acquisition or Disposition of Assets (Form 8-K)	PU
15/07/21	CONSTELLATION PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
14/06/21	Constellation Pharmaceuticals : Provides an Update from the Ongoing MANIFEST Study of Pelabresib	AQ
11/06/21	Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib	GL
07/06/21	Constellation Pharmaceuticals : Presents Phase 1 Data for CPI-0209 at ASCO Annual Meeting	AQ
04/06/21	Constellation Pharmaceuticals : Corporate Presentation—June 4, 2021	PU
04/06/21	Constellation Pharmaceuticals : Poster Presentation of Phase 1/2 First-in-Human (FIH) Study of CPI-0209 in Patients With Advanced Tumors, Presented at ACRO, June 4, 2021	PU
04/06/21	Constellation Pharmaceuticals : Presents Phase 1 Data for CPI-0209 at ASCO Annual Meeting	AQ
02/06/21	CONSTELLATION PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
02/06/21	Constellation Pharmaceuticals : MorphoSys to Acquire Constellation Pharmaceuticals (Form 8-K)	PU
02/06/21	CONSTELLATION PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
02/06/21	Constellation Pharmaceuticals : (CNST Alert) Johnson Fistel Investigates Proposed Sale of Constellation Pharmaceuticals; Are Shareholders Getting a Fair Deal?	PR
02/06/21	Constellation Pharmaceuticals : German biotech company MorphoSys buys US rival for $1.7B	AQ
02/06/21	Constellation Pharmaceuticals : MorphoSys to Acquire Constellation Pharmaceuticals	BU
31/05/21	Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference	GL
10/05/21	Constellation Pharmaceuticals : CNST 1Q 2021 Earnings Presentation	PU
10/05/21	Constellation Pharmaceuticals : Corporate Presentation—May 10, 2021	PU
10/05/21	Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update	GL
10/05/21	CONSTELLATION PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
27/04/21	Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2021 Results	GL
12/04/21	Constellation Pharmaceuticals : Poster Presentation of CPI-0209 in Preclinical Prostate Cancer Model, Presented at AACR, April 12, 2021	PU
24/02/21	Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results	GL
24/02/21	CONSTELLATION PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
22/02/21	Constellation Pharmaceuticals : to Participate in the 10th Annual SVB Leerink Global Healthcare Conference	AQ
19/02/21	Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference	GL